Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
We investigate the associations of three established plasma biomarkers in the context of HIV and treatment-related variables including a comprehensive cardiovascular disease risk assessment, within a large ambulatory HIV cohort. Patients were recruited in 2010 to form the Royal Perth Hospital HIV/CV...
Main Authors: | Alison Castley, Leah Williams, Ian James, George Guelfi, Cassandra Berry, David Nolan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4927121?pdf=render |
Similar Items
-
sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence
by: Andrea Aprilia, et al.
Published: (2024-01-01) -
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection.
by: Claudia Mascia, et al.
Published: (2018-01-01) -
The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology
by: Andriana Plevriti, et al.
Published: (2024-10-01) -
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
by: Jose Gómez-Rial, et al.
Published: (2020-09-01) -
Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD
by: Rui Zhang, et al.
Published: (2022-06-01)